203 related articles for article (PubMed ID: 36091335)
1. Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience.
Zheng Z; Guan R; Zou Y; Jian Z; Lin Y; Guo R; Jin H
J Inflamm Res; 2022; 15():5089-5102. PubMed ID: 36091335
[TBL] [Abstract][Full Text] [Related]
2. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
Liao R; Wei XF; Che P; Yin KL; Liu L
Front Oncol; 2021; 11():755920. PubMed ID: 35127471
[TBL] [Abstract][Full Text] [Related]
3. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
[TBL] [Abstract][Full Text] [Related]
4. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
5. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
6. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
7. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
[TBL] [Abstract][Full Text] [Related]
8. Prognostic nomograms for HBV-related BCLC 0-a stage hepatocellular carcinoma incorporating aspartate aminotransferase to albumin ratio.
Wu Y; Peng W; Shen J; Zhang X; Li C; Wen TF
Scand J Gastroenterol; 2023 Jul; 58(7):789-797. PubMed ID: 36620916
[TBL] [Abstract][Full Text] [Related]
9. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma.
Tian Y; Wang Y; Wen N; Lin Y; Liu G; Li B
Front Oncol; 2024; 14():1395740. PubMed ID: 38854717
[TBL] [Abstract][Full Text] [Related]
11. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy.
Xia W; Peng T; Guan R; Zhou Y; Zeng C; Lin Y; Wu Z; Tan H
Ann Transl Med; 2021 Oct; 9(20):1541. PubMed ID: 34790747
[TBL] [Abstract][Full Text] [Related]
13. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
14. Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma.
Lin K; Huang Q; Wang L; Zeng J; Ding Z; Liu H; Fu J; Guo P; Chen Z; Zeng Y; Zhou W; Liu J
Front Oncol; 2021; 11():612588. PubMed ID: 33680963
[TBL] [Abstract][Full Text] [Related]
15. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
[TBL] [Abstract][Full Text] [Related]
16. Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study.
Liu X; Qiu Z; Ndhlovu E; Wan Y; Sun H; Wang S; Cao Y; Zhu P
J Hepatocell Carcinoma; 2024; 11():1127-1141. PubMed ID: 38895590
[TBL] [Abstract][Full Text] [Related]
17. Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Ma E; Li J; Xing H; Li R; Shen C; Zhang Q; Ma Z; Tao Y; Qin L; Zhao J; Wang Z
Ann Transl Med; 2021 Mar; 9(6):468. PubMed ID: 33850865
[TBL] [Abstract][Full Text] [Related]
18. A Practical Nomogram and Risk Stratification System Predicting the Cancer-Specific Survival for Patients With Advanced Hepatocellular Carcinoma.
Yang D; Su Y; Zhao F; Chen C; Zhao K; Xiong X; Ding Y
Front Oncol; 2022; 12():914192. PubMed ID: 35903694
[TBL] [Abstract][Full Text] [Related]
19. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
[No Abstract] [Full Text] [Related]
20. A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver Fibrosis.
Yang D; Su Y; Zhao F; Chen C; Zhao K; Xiong X; Ding Y
Front Surg; 2022; 9():920589. PubMed ID: 35784933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
